InvestorsHub Logo

Whoops

01/19/15 6:46 PM

#87893 RE: Ultimate01 #87890

Ultimate, the heptagonist was Delparantag which the company is now looking at as treatment for COPD Chronic Obstructive Pulmonary Disease its the 3rd leading killer in humans in the US.

At bottom of link: http://cellceutix.com/cellceutix-provides-update-to-shareholders/#sthash.1wbV6WmE.dpbs